{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:52:34Z","timestamp":1761922354271,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T00:00:00Z","timestamp":1568678400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008431","name":"Consejer\u00eda de Educaci\u00f3n, Junta de Castilla y Le\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012637","name":"University of the East","doi-asserted-by":"publisher","award":["LE020P17"],"award-info":[{"award-number":["LE020P17"]}],"id":[{"id":"10.13039\/501100012637","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["AGL2016-79813-C2-1R","SAF2017-83575-R"],"award-info":[{"award-number":["AGL2016-79813-C2-1R","SAF2017-83575-R"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijpddr.2019.09.005","type":"journal-article","created":{"date-parts":[[2019,9,20]],"date-time":"2019-09-20T02:06:29Z","timestamp":1568945189000},"page":"39-48","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum"],"prefix":"10.1016","volume":"11","author":[{"given":"Camino","family":"Guti\u00e9rrez-Corbo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"\u00c1lvarez-Velilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosa M.","family":"Reguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Garc\u00eda-Estrada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Bala\u00f1a-Fouce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yolanda","family":"P\u00e9rez-Pertejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpddr.2019.09.005_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib2","doi-asserted-by":"crossref","first-page":"10397","DOI":"10.1158\/0008-5472.CAN-07-0938","article-title":"Novel indenoisoquinolines NSC 725776 and NSC 724998 produce persistent topoisomerase I cleavage complexes and overcome multidrug resistance","volume":"67","author":"Antony","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib3","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1128\/AAC.00650-07","article-title":"Activity of indenoisoquinolines against African trypanosomes","volume":"53","author":"Bakshi","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib4","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijpddr.2014.07.006","article-title":"Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery","volume":"4","author":"Bala\u00f1a-Fouce","year":"2014","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib5","doi-asserted-by":"crossref","first-page":"5264","DOI":"10.1128\/AAC.00499-12","article-title":"Indotecan (LMP400) and AM13-55: two novel indenoisoquinolines show potential for treating visceral leishmaniasis","volume":"56","author":"Bala\u00f1a-Fouce","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1365-2958.2010.07318.x","article-title":"A tyrosyl DNA phosphodiesterase 1 from kinetoplastid parasite Leishmania donovani (LdTdp1) capable of removing topo I-DNA covalent complexes","volume":"78","author":"Banerjee","year":"2010","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/519690","article-title":"Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis","volume":"196","author":"Bhattacharya","year":"2007","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib8","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(18)31204-2","article-title":"Leishmaniasis","volume":"392","author":"Burza","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005781","article-title":"Systematic review of clinical trials assessing the therapeutic efficacy of visceral leishmaniasis treatments a first step to assess the feasibility of establishing an individual patient data sharing platform","volume":"11","author":"Bush","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003666","article-title":"Infrared fluorescent imaging as a potent tool for in vitro, ex vivo and in vivo models of visceral leishmaniasis","volume":"9","author":"Calvo-\u00c1lvarez","year":"2015","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.biochem.70.1.369","article-title":"DNA topoisomerases: structure, function, and mechanism","volume":"70","author":"Champoux","year":"2001","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib12","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.tibs.2018.12.001","article-title":"DNA Topoisomerases in unicellular pathogens: structure, function, and druggability","volume":"44","author":"Chowdhury","year":"2019","journal-title":"Trends Biochem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib13","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/mmi.13441","article-title":"Functional compartmentalization of Rad9 and Hus1 reveals diverse assembly of the 9-1-1 complex components during the DNA damage response in Leishmania","volume":"10","author":"Damasceno","year":"2016","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib14","doi-asserted-by":"crossref","first-page":"11835","DOI":"10.1093\/nar\/gky1017","article-title":"Conditional genome engineering reveals canonical and divergent roles for the Hus1 component of the 9-1-1 complex in the maintenance of the plastic genome of Leishmania","volume":"46","author":"Damasceno","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib15","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2174\/187152008784220357","article-title":"Tyrosyl-DNA phosphodiesterase as a target for anticancer therapy","volume":"8","author":"Dexheimer","year":"2008","journal-title":"Anti Cancer Agents Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib16","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib17","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpddr.2017.06.003","article-title":"Antileishmanial activity and tubulin polymerization inhibition of podophyllotoxin derivatives on Leishmania infantum","volume":"7","author":"Escudero-Mart\u00ednez","year":"2017","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib18","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.3390\/molecules14072317","article-title":"Pentavalent antimonials: new perspectives for old drugs","volume":"14","author":"Fr\u00e9zard","year":"2009","journal-title":"Molecules"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib19","doi-asserted-by":"crossref","first-page":"20303","DOI":"10.1074\/jbc.M300198200","article-title":"Phosphorylation of histone H2AX and activation of Mre11, Rad50, and Nbs1 in response to replication-dependent DNA double-strand breaks induced by mammalian DNA topoisomerase I cleavage complexes","volume":"278","author":"Furuta","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib20","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.molbiopara.2012.01.008","article-title":"Trypanosomal histone \u03b3H2A and the DNA damage response","volume":"183","author":"Glover","year":"2012","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib21","first-page":"5077","article-title":"Arrest of replication forks by drug stabilized topoisomerase I-DNA cleavable complexes as a mechanism of cell killing by camptothecin","volume":"49","author":"Hsiang","year":"1989","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib22","doi-asserted-by":"crossref","first-page":"14873","DOI":"10.1016\/S0021-9258(17)38654-4","article-title":"Camptothecin induces protein-linked DNA break via mammalian DNA topoisomerase I","volume":"260","author":"Hsiang","year":"1985","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib23","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/13543776.2011.604314","article-title":"Tyrosyl-dna phosphodiesterase 1 (Tdp1) inhibitors","volume":"21","author":"Huang","year":"2011","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib24","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/cyto.a.20018","article-title":"Assessment of histone H2AX phosphorylation induced by DNA topoisomerase I and II inhibitors topotecan and mitoxantrone and by the DNA cross-linking agent cisplatin","volume":"58","author":"Huang","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib25","doi-asserted-by":"crossref","first-page":"614","DOI":"10.4161\/cc.2.6.565","article-title":"DNA damage induced by DNA topoisomerase I\u2010 and topoisomerase II\u2010 inhibitors detected by histone H2AX phosphorylation in relation to the cell cycle phase and apoptosis","volume":"2","author":"Huang","year":"2003","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/08982104.2017.1380664","article-title":"The care and feeding of a commercial liposomal product: liposomal amphotericin B (AmBisome\u00ae)","volume":"27","author":"Jensen","year":"2017","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib27","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s40261-016-0481-0","article-title":"Safety and effectiveness of sodium stibogluconate and paromomycin combination for the treatment of visceral leishmaniasis in eastern Africa: results from a pharmacovigilance programme","volume":"37","author":"Kimutai","year":"2017","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib28","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1093\/nar\/gkn550","article-title":"Gamma-H2AX in recognition and signalling of DNA double-strand breaks in the context of chromatin","volume":"36","author":"Kinner","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib30","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1021\/jm200719v","article-title":"7-azaindenoisoquinolines as topoisomerase I inhibitors and potential anticancer agents","volume":"54","author":"Kiselev","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib31","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1021\/jm070361q","article-title":"Nitrated indenoisoquinolines as topoisomerase I inhibitors: a systematic study and optimization","volume":"50","author":"Morrell","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13014-015-0453-1","article-title":"The Focinator - a new open-source tool for high-throughput foci evaluation of DNA damage","volume":"10","author":"Oeck","year":"2015","journal-title":"Radiat. Oncol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib33","first-page":"1577","article-title":"Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro","volume":"53","author":"Pantazis","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib34","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1093\/nar\/gkw109","article-title":"Immunodetection of human topoisomerase I-DNA covalent complexes","volume":"44","author":"Patel","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib35","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1021\/cb300648v","article-title":"Drugging topoisomerases: lessons and challenges","volume":"8","author":"Pommier","year":"2013","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib36","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1016\/j.bmcl.2015.07.032","article-title":"Interfacial inhibitors","volume":"25","author":"Pommier","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib37","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.chembiol.2010.04.012","article-title":"DNA Topoisomerases and their poisoning by anticancer and antibacterial drugs","volume":"17","author":"Pommier","year":"2010","journal-title":"Chem. Biol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/nrm.2016.111","article-title":"Roles of eukaryotic topoisomerases in transcription, replication and genomic stability","volume":"17","author":"Pommier","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib39","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1016\/j.bcp.2013.02.024","article-title":"Gimatecan and other camptothecin derivatives poison Leishmania DNA-topoisomerase IB leading to a strong leishmanicidal effect","volume":"85","author":"Prada","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib40","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.1073\/pnas.0830918100","article-title":"Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses","volume":"100","author":"Rothkamm","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib41","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1021\/jm049146p","article-title":"Structures of three classes of anticancer agents bound to the human topoisomerase I-DNA covalent complex","volume":"48","author":"Staker","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib42","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1126\/science.279.5356.1534","article-title":"A model for the mechanism of human topoisomerase I","volume":"279","author":"Stewart","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib43","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Amphotericin B (AmBisome\u00ae): a review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.ijpddr.2019.09.005_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1056\/NEJMoa0903627","article-title":"Single-dose liposomal amphotericin B for visceral leishmaniasis in India","volume":"362","author":"Sundar","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00688-17","article-title":"Efficacy of a binuclear cyclopalladated compound therapy for cutaneous leishmaniasis in the murine model of infection with Leishmania amazonensis and its inhibitory effect on topoisomerase 1B","volume":"61","author":"Vel\u00e1squez","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib46","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1074\/jbc.M203991200","article-title":"A novel active DNA topoisomerase I in Leishmania donovani","volume":"278","author":"Villa","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijpddr.2019.09.005_bib47","doi-asserted-by":"crossref","first-page":"3275","DOI":"10.1021\/acs.jmedchem.6b01565","article-title":"Synthesis and biological evaluation of the first triple inhibitors of human topoisomerase 1, tyrosyl-DNA phosphodiesterase 1 (Tdp1), and tyrosyl-DNA phosphodiesterase 2 (Tdp2)","volume":"60","author":"Wang","year":"2017","journal-title":"J. Med. Chem."}],"container-title":["International Journal for Parasitology: Drugs and Drug Resistance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211320719300818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:48:49Z","timestamp":1761922129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211320719300818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":46,"alternative-id":["S2211320719300818"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.09.005","relation":{},"ISSN":["2211-3207"],"issn-type":[{"type":"print","value":"2211-3207"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topoisomerase IB poisons induce histone H2A phosphorylation as a response to DNA damage in Leishmania infantum","name":"articletitle","label":"Article Title"},{"value":"International Journal for Parasitology: Drugs and Drug Resistance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpddr.2019.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd on behalf of Australian Society for Parasitology.","name":"copyright","label":"Copyright"}]}}